Discover 95 paid clinical trials in Great Falls, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 95
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: 41 recruiting locations
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence
for
Stress Urinary Incontinence (SUI)
Location: 7 recruiting locations
Sponsor: Acoustic Wave Cell Therapy, Inc.
Sex: Female
Age: 22 - 70+
Code: NCT06862648
Recruiting
Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial
for
Metastatic Malignant Neoplasm in the Bone,
Location: 380 recruiting locations
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06745024
Phase3, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: 199 recruiting locations
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase3, Recruiting
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
for
Stage III Cutaneous Melanoma AJCC v7,
Location: 372 recruiting locations
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT02339571
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
for
Breast Cancer
Location: 325 recruiting locations
Sponsor: Canadian Cancer Trials Group
Sex: Female
Age: 35+
Code: NCT03488693
Phase3, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: 114 recruiting locations
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: 205 recruiting locations
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
for
Carotid Artery Diseases
Location: 8 recruiting locations
Sponsor: InspireMD
Sex: All
Age: 18 - 70+
Code: NCT06653387
Recruiting
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study